Matthew Hepburn, MD

home / authors / matthew-hepburn-md

Hepburn is executive vice president of Research and Development at Panther Life Sciences.

Articles

Operation Warp Speed: Bringing Out the Best in America’s Ability to Innovate

April 28th 2025

Matthew Hepburn, MD, offers some insights on his time as vaccine development lead for Operation Warp Speed and the ability to develop a COVID-19 vaccine within a year.

Panther's Microarray Patch Offers Novel Therapy Delivery System for Potential Infectious Disease Applications

John Parkinson;Matthew Hepburn, MD

April 18th 2025

Matthew Hepburn, MD, executive vice president of research and development at Panther Life Sciences, discusses the technology and its potential usage.

Published: August 27th 2024 | Updated: August 28th 2024

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties

Published: April 25th 2025 | Updated: April 30th 2025

FDA Requests Additional Trial of Novavax NVX-CoV2601 Vaccine Prior to Approval

Published: April 23rd 2025 | Updated: April 30th 2025

Next-Generation Antivirals Outperform Paxlovid in Preclinical Coronavirus Testing

Published: April 21st 2025 | Updated: April 30th 2025

The Impact of the Pandemic on Antimicrobial Resistance

Published: April 23rd 2025 | Updated: April 23rd 2025

CDC Reports 800 Confirmed Measles Cases Across the US, 624 Being in Texas

Published: April 23rd 2025 | Updated: April 30th 2025

Working to Prevent Malaria Through Genomic Research, Education

Do Not Sell My Information

Privacy

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Matthew Hepburn, MD

Articles

Latest Updated Articles